# A Research Study of VCT220 in Adult Chinese Participants With Obesity

> **NCT06939296** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Vincentage Pharma Co., Ltd** · enrollment: 840 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** VCT220
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06939296
- **Lead sponsor:** Vincentage Pharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-24
- **Primary completion:** 2025-11-25
- **Final completion:** 2026-03-31
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06939296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06939296, "A Research Study of VCT220 in Adult Chinese Participants With Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06939296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*